Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Braemar Hotels stock slides 13% as 2027 profit outlook disappoints
Braemar Hotels & Resorts shares dropped about 13% after the hotel REIT's 2027 outlook missed on a key profit measure. The forecast showed ho
Barksdale Resources raises CA$13.2M to fund Arizona drilling push
Barksdale Resources has raised CA$13.2 million to accelerate exploration at its Arizona copper projects. The funds will support a phased 16,
Brookdale occupancy growth slows in Q3, RBC trims forecast
RBC estimates Brookdale Senior Living's Q3 occupancy at 83.1%, up from a year ago but slightly below its forecast. The firm trimmed its 2026
Viatris' $36.50 Pacira bid looks tough to beat, RBC says
Viatris' all-cash $36.50-a-share offer for Pacira Biosciences is designed to close fast, and RBC Capital Markets thinks that leaves little r
Pilgrim's Pride forms committee to weigh JBS's take-private offer
Pilgrim's Pride has formed an independent committee to evaluate JBS's unsolicited take-private offer of $28.49 per share. The bid, which mat
Vertex secures CA$7M loan at 15% with compounding interest
Vertex Resource Group is arranging a CA$7 million subordinated loan at 15% annual interest, with part of the cost compounding. The deal also
Jio Platforms targets India's biggest IPO with $125B valuation
Jio Platforms, the telecom and digital arm of Reliance Industries, is preparing an IPO that could be India's largest ever. The company is ta
SpaceX's $8B spectrum deal rattles telecom stocks, lifts tower firms
Telecom stocks slid after reports that SpaceX agreed to buy a nationwide low-band spectrum portfolio for about $8 billion. The deal revived
SpaceX leads WallStreetBets favorites higher in premarket rebound
SpaceX jumped about 4% in premarket trading after agreeing to buy 800 MHz spectrum licenses to expand Starlink Mobile coverage. Other WallSt
BASF weighs higher Evonik bid with job guarantees after €10.3bn rejection
BASF is considering a higher takeover offer for German chemicals firm Evonik after its €10.3bn bid was rejected. The company may also add jo
Sartorius Stedim's 2027 margin story drives price target hike to €253
AlphaValue/Baader Europe lifted its price target on Sartorius Stedim to €253, even as it trimmed 2026-27 earnings forecasts. The firm sees f
Sleep Cycle's $215M Audiowell Deal Hands Seller 82% Stake
Sleep Cycle is acquiring Sweden's Audiowell in a 2.26 billion kronor all-stock deal. The seller will end up with an 82% stake, and the trans